AFP and hepatocellular carcinoma: In first clinical trials, vaccinations against tumor-associated antigens (TAA), such as Alpha-Fetoprotein (AFP) using dendritic cells (DC) failed to achieve effective immune responses towards hepatocellular carcinoma (HCC) [13,15,16].